Search results
Results from the WOW.Com Content Network
On November 12, 2021, Johnson & Johnson announced that it would spin off its consumer health division as a separate company, in an effort to streamline operations. [3] The new company would assume well-known consumer brands such as Aveeno, Band-Aid, Neutrogena, and Tylenol, while Johnson & Johnson would focus on its pharmaceutical and medical device sectors. [3]
J&JPRD has research sites located in Raritan, New Jersey, Titusville, New Jersey, Spring House, Pennsylvania, La Jolla, California, Beerse, Belgium and Toledo, Spain. J&JPRD was created in 2001 through the merging of various research organizations including McNeil Pharmaceuticals , Janssen Research Foundation , Three Dimensional Pharmaceuticals ...
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business sector into a new publicly traded company, Kenvue .
For premium support please call: 800-290-4726 more ways to reach us
Ortho Clinical Diagnostics (now QuidelOrtho) is an in vitro diagnostics company that made products and diagnostic equipment for blood testing.Ortho served two primary industries in the medical field: clinical laboratories, by producing platforms and assays that test for a variety of diseases, conditions, and substances; and immunohematology, by providing the means to ensure blood transfusion ...
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.
A Middlesex County jury ordered Johnson & Johnson to pay a total of $37.3 million to four sets of plaintiffs who said they developed mesothelioma from asbestos in baby powder. ... New Jersey State ...
Johnson & Johnson now expects 2024 operational growth of 6.4% as a midpoint target compared to the prior 5.8% estimate. Maybe even more importantly, the trends are expected to continue into 2025 ...